Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 04:00PM ET
Dollar change
Percentage change
Index- P/E5.30 EPS (ttm)4.08 Insider Own0.20% Shs Outstand257.17M Perf Week2.22%
Market Cap5.56B Forward P/E4.71 EPS next Y4.59 Insider Trans0.53% Shs Float256.66M Perf Month2.41%
Income1.05B PEG1.83 EPS next Q1.11 Inst Own83.17% Short Float3.23% Perf Quarter16.79%
Sales6.35B P/S0.88 EPS this Y7.91% Inst Trans-0.05% Short Ratio4.87 Perf Half Y32.94%
Book/sh0.19 P/B115.29 EPS next Y2.77% ROA9.24% Short Interest8.28M Perf Year0.46%
Cash/sh2.24 P/C9.67 EPS next 5Y2.90% ROE- 52W Range10.84 - 24.08 Perf YTD50.00%
Dividend Est.1.00 (4.62%) P/FCF10.91 EPS past 5Y-14.04% ROI11.96% 52W High-10.17% Beta0.80
Dividend TTM1.12 (5.18%) Quick Ratio1.15 Sales past 5Y-7.62% Gross Margin59.04% 52W Low99.63% ATR (14)0.58
Dividend Ex-DateMay 10, 2024 Current Ratio1.65 EPS Y/Y TTM39.63% Oper. Margin21.22% RSI (14)62.27 Volatility2.86% 2.66%
Employees10000 Debt/Eq181.54 Sales Y/Y TTM3.29% Profit Margin16.50% Recom2.56 Target Price22.50
Option/ShortYes / Yes LT Debt/Eq181.35 EPS Q/Q12.61% Payout28.06% Rel Volume0.71 Prev Close21.46
Sales Surprise3.63% EPS Surprise24.76% Sales Q/Q5.46% EarningsAug 06 BMO Avg Volume1.70M Price21.63
SMA204.65% SMA503.66% SMA20025.86% Trades Volume1,211,395 Change0.79%
Date Action Analyst Rating Change Price Target Change
Nov-03-23Downgrade Goldman Buy → Neutral $33 → $16
Sep-21-23Initiated Barclays Overweight $28
Mar-16-23Initiated Raymond James Outperform $33
Oct-14-22Downgrade BofA Securities Neutral → Underperform $27 → $25
Sep-06-22Upgrade Piper Sandler Neutral → Overweight $37 → $34
Aug-05-22Downgrade BofA Securities Buy → Neutral $40 → $37
Apr-27-22Initiated Goldman Buy $40
Apr-06-22Resumed Morgan Stanley Equal-Weight $35
Oct-07-21Initiated Piper Sandler Neutral $35
Sep-01-21Initiated BofA Securities Buy $43
Jul-24-24 12:00PM
Jul-09-24 06:00PM
Jun-28-24 09:41AM
Jun-26-24 06:00PM
01:35PM Loading…
Jun-20-24 06:00PM
Jun-12-24 09:00AM
Jun-03-24 09:35AM
May-30-24 09:00AM
May-24-24 06:00AM
May-14-24 12:20PM
May-07-24 08:20PM
07:58AM Loading…
May-03-24 12:37PM
May-02-24 12:00PM
May-01-24 01:26PM
Apr-29-24 10:26AM
Apr-25-24 10:01AM
Apr-22-24 06:15PM
Apr-21-24 10:39AM
Apr-12-24 11:08AM
06:15AM Loading…
Apr-08-24 06:15AM
Apr-01-24 04:05PM
Mar-08-24 09:01AM
Mar-05-24 02:56AM
Feb-20-24 08:00AM
Feb-16-24 09:47AM
Feb-15-24 11:00AM
Feb-14-24 08:05AM
Feb-01-24 07:30AM
Jan-12-24 06:53AM
Jan-10-24 07:33AM
Jan-08-24 07:30AM
Dec-21-23 07:30AM
Dec-18-23 07:30AM
Nov-21-23 07:30AM
Nov-15-23 10:16AM
Nov-07-23 04:15PM
Nov-02-23 07:30AM
Nov-01-23 07:30AM
Oct-26-23 07:00AM
Oct-19-23 07:30AM
Oct-13-23 06:02PM
Oct-06-23 03:07PM
Sep-27-23 07:30AM
Sep-26-23 07:01AM
Sep-14-23 05:12PM
Sep-05-23 10:00AM
Aug-08-23 07:30AM
Aug-01-23 07:00AM
Jul-17-23 07:30AM
Jul-05-23 08:00AM
Jul-01-23 06:30AM
Jun-27-23 07:30AM
Jun-21-23 08:00PM
Jun-07-23 07:30AM
May-18-23 12:28PM
May-04-23 07:30AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-20-23 07:30AM
Apr-19-23 07:47AM
Mar-07-23 07:00AM
Mar-03-23 07:30AM
Feb-27-23 07:30AM
Feb-16-23 07:30AM
Feb-13-23 06:43AM
Feb-06-23 07:30AM
Jan-27-23 12:10PM
Jan-05-23 07:30AM
Dec-15-22 07:30AM
Dec-12-22 08:00AM
Nov-15-22 07:30AM
Nov-14-22 07:40AM
Nov-07-22 07:30AM
Nov-03-22 07:30AM
Oct-20-22 07:30AM
Sep-26-22 07:00AM
Aug-17-22 07:30AM
Aug-07-22 08:29AM
Aug-04-22 07:30AM
Jul-28-22 07:30AM
Jul-25-22 10:24AM
Jul-21-22 07:30AM
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALSH MATTHEW MChief Financial OfficerMay 04 '24Option Exercise0.008,310092,419May 07 04:05 PM
DiMarco KathrynCorporate ControllerMay 04 '24Option Exercise0.001,248021,398May 07 04:05 PM
Falcione AaronChief Human Resources OfficerMay 04 '24Option Exercise0.002,770031,364May 07 04:05 PM
Weaver KirkeGen. Counsel & Corp. Secy.May 04 '24Option Exercise0.001,248029,516May 07 04:06 PM
Ali KevinChief Executive OfficerMay 04 '24Option Exercise0.0022,1610147,504May 07 04:06 PM
Fiedler SusanneChief Commercial OfficerMay 04 '24Option Exercise0.004,989052,253May 07 04:06 PM
Nisita VittorioHead of Global Business SvcsMay 04 '24Option Exercise0.002,078023,097May 07 04:07 PM
Morrissey Joseph T. Jr.Head of ManufacturingMay 04 '24Option Exercise0.003,604042,406May 07 04:07 PM
Stahler Rachel AChief Information OfficerMay 04 '24Option Exercise0.003,049049,282May 07 04:04 PM
Nisita VittorioHead of Global Business SvcsMar 31 '24Option Exercise0.007,469022,597Apr 03 06:41 PM
WALSH MATTHEW MChief Financial OfficerMar 31 '24Option Exercise0.0019,799090,042Apr 03 06:42 PM
Fiedler SusanneChief Commercial OfficerMar 31 '24Option Exercise0.0012,565049,747Apr 03 06:42 PM
Morrissey Joseph T. Jr.Head of ManufacturingMar 31 '24Option Exercise0.0011,730041,130Apr 03 06:42 PM
Weaver KirkeGen. Counsel & Corp. Secy.Mar 31 '24Option Exercise0.0013,619029,159Apr 03 06:40 PM
Falcione AaronChief Human Resources OfficerMar 31 '24Option Exercise0.0010,309030,900Apr 03 06:41 PM
Ali KevinChief Executive OfficerMar 31 '24Option Exercise0.0060,4440146,896Apr 03 06:41 PM
DiMarco KathrynCorporate ControllerMar 31 '24Option Exercise0.0012,797023,063Apr 03 06:40 PM
Weaver KirkeGen. Counsel & Corp. Secy.Feb 22 '24Buy18.362,72049,93915,181Feb 23 11:46 AM
DiMarco KathrynCorporate ControllerFeb 09 '24Option Exercise0.001,87109,388Feb 13 04:16 PM